[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.145.213.148. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correction
March 14, 2005

The Effects of Cyclooxygenase-2 [COX-2] Inhibitors and Nonsteroidal Anti-inflammatory Therapy on 24-Hour Blood Pressure in Patients With Hypertension, Osteoarthritis, and Type 2 Diabetes Mellitus—Correction

Arch Intern Med. 2005;165(5):551. doi:10.1001/archinte.165.5.551

Error in Editor’s Note. In the Editor’s Note that appeared with the article “The Effects of Cyclooxygenase-2 [COX-2] Inhibitors and Nonsteroidal Anti-inflammatory Therapy on 24-Hour Blood Pressure in Patients With Hypertension, Osteoarthritis, and Type 2 Diabetes Mellitus” (2005;165:161-168), the word “former” was used instead of the word “latter.” The corrected sentence reads as follows: “The 4 articles on COX-2 inhibitors in this issue of the ARCHIVES demonstrate continued reason for concern about adverse cardiovascular effects of both rofecoxib and celecoxib (though less so for the latter) as well as serious concern about the apparent overuse of these drugs in the prescription marketplace.”

×